$glp-1 cv outcome trials Impact of receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology GLP-1 receptor agonists for cardiovascular$

glp-1 cv outcome trials

glp-1 cv outcome trials Impact of receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology GLP-1 receptor agonists for cardiovascular

Name: glp-1 cv outcome trials Impact of receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology GLP-1 receptor agonists for cardiovascular
Brand: actil.am
SKU: 75382239993
Price: 28.39 USD
Availability: InStock
Rating: 4.7092 (24 reviews)

SKU: 75382239993

4.7

USD28.39 USD67.39

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

To groups of five anaesthetized rats, peptides (exenatide or semaglutide) in sterile Dulbeccos phosphate buffer saline (DPBS) (Biowest, L0615) were administered by intravenous injection via the tail vein